Exact Sciences (EXAS) Cash from Investing Activities (2010 - 2025)

Exact Sciences (EXAS) has 16 years of Cash from Investing Activities data on file, last reported at $91.1 million in Q4 2025.

• Cash from Investing Activities for Q4 2025 came in at $91.1 million, up 317.61% year-over-year; the trailing twelve-month figure through Dec 2025 was $195.1 million (up 144.13% YoY), and the FY2025 annual result was $195.1 million, up 144.13% from the prior year.
• Cash from Investing Activities improved to $91.1 million in Q4 2025 per EXAS's latest filing, from -$86.5 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $224.9 million in Q2 2025 and troughed at -$793.8 million in Q2 2021.
• A 5-year average of -$60.3 million and a median of -$38.2 million in 2024 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2021 and 2025: Cash from Investing Activities sank 12341.49% in 2021, then surged 317.61% in 2025.
• A 5-year view of Cash from Investing Activities shows it stood at $78.4 million in 2021, then slumped by 174.15% to -$58.2 million in 2022, then slipped by 14.8% to -$66.8 million in 2023, then surged by 37.29% to -$41.9 million in 2024, then jumped by 317.61% to $91.1 million in 2025.
• Business Quant data shows EXAS's Cash from Investing Activities at $91.1 million in Q4 2025, -$86.5 million in Q3 2025, and $224.9 million in Q2 2025.